T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome

Viruses

Volumn 3, Issue 7, 2011, Pages 1059-1073

  Terajima, Masanori ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

CD8 + T cell; Endothelial cell; Hantavirus; Hantavirus cardiopulmonary syndrome; Hemorrhagic fever with renal syndrome; Immunopathogenesis; Regulatory T cell

Indexed keywords

GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA B27 ANTIGEN; HLA B8 ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANTIGEN PRESENTATION; CAPILLARY PERMEABILITY; CD8+ T LYMPHOCYTE; CLINICAL OBSERVATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; DISEASE SEVERITY; ENDOTHELIUM CELL; GENETIC SUSCEPTIBILITY; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IN VITRO STUDY; LYMPHOCYTE DEPLETION; NONHUMAN; PATHOGENESIS; PUUMALA VIRUS; REGULATORY T LYMPHOCYTE; REVIEW; SEOUL VIRUS; SIN NOMBRE VIRUS; T LYMPHOCYTE; VIRAL CLEARANCE;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; T-LYMPHOCYTES;

HANTAVIRUS; RATTUS;

EID: 79960781684     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3071059     Document Type: Review

References (101)

1. Schmaljohn, C.S.; Nichol, S.T. Bunyaviridae. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 1742-1789.
2. Hjelle, B.; Torres-Pérez, F. Hantaviruses in the Americas and their role as emerging pathogens. Viruses 2010, 2, 2559-2586.
3. Kanerva, M.; Mustonen, J.; Vaheri, A. Pathogenesis of puumala and other hantavirus infections. Rev. Med. Virol. 1998, 8, 67-86.
4. Peters, C.J.; Simpson, G.L.; Levy, H. Spectrum of hantavirus infection: Hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu. Rev. Med. 1999, 50, 531-545.
5. Rasmuson, J.; Andersson, C.; Norrman, E.; Haney, M.; Evander, M.; Ahlm, C. Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30, 685-690.
6. Pergam, S.A.; Schmidt, D.W.; Nofchissey, R.A.; Hunt, W.C.; Harford, A.H.; Goade, D.E. Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am. J. Trop. Med. Hyg. 2009, 80, 279-285.
7. Centers for Disease Control and Prevention. Available online: http://www.cdc.gov/ncidod/diseases/hanta/hps/noframes/caseinfo.htm (accessed on 6 May 2011).
8. Yi, X.P.; Xing, S.F. The distribution of epidemic hemorrhagic fever (EHF) viral antigen in tissues from EHF autopsies. Zhonghua Bing Li Xue Za Zhi 1991, 20, 110-112.
9. Zhu, P.; Yang, W.S. Effects of Hantaan virus on human endothelial cells and their significance in pathogenesis of hemorrhagic fever with renal syndrome. Chin. Med. J. (Engl.) 1991, 104, 924-929.
10. Zaki, S.R.; Greer, P.W.; Coffield, L.M.; Goldsmith, C.S.; Nolte, K.B.; Foucar, K.; Feddersen, R.M.; Zumwalt, R.E.; Miller, G.L.; Khan, A.S., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 1995, 146, 552-579.
11. Mertz, G.J.; Hjelle, B.L.; Bryan, R.T. Hantavirus infection. Adv. Intern. Med. 1997, 42, 369-421.
12. Yanagihara, R.; Silverman, D.J. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch. Virol. 1990, 111, 281-286.
13. Pensiero, M.N.; Sharefkin, J.B.; Dieffenbach, C.W.; Hay, J. Hantaan virus infection of human endothelial cells. J. Virol. 1992, 66, 5929-5936.
14. Geimonen, E.; Neff, S.; Raymond, T.; Kocer, S.S.; Gavrilovskaya, I.N.; Mackow, E.R. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 13837-13842.
15. Niikura, M.; Maeda, A.; Ikegami, T.; Saijo, M.; Kurane, I.; Morikawa, S. Modification of endothelial cell functions by Hantaan virus infection: Prolonged hyper-permeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers. Arch. Virol. 2004, 149, 1279-1292.
16. Khaiboullina, S.F.; Netski, D.M.; Krumpe, P.; Jeor, S.C. Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. J. Virol. 2000, 74, 11966-11971.
17. Sundstrom, J.B.; McMullan, L.K.; Spiropoulou, C.F.; Hooper, W.C.; Ansari, A.A.; Peters, C.J.; Rollin, P.E. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 2001, 75, 6070-6085.
18. Hayasaka, D.; Maeda, K.; Ennis, F.A.; Terajima, M. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res. 2007, 123, 120-127.
19. Mackow, E.R.; Gavrilovskaya, I.N. Hantavirus regulation of endothelial cell functions. Thromb. Haemost. 2009, 102, 1030-1041.
20. Cosgriff, T.M. Mechanisms of disease in Hantavirus infection: Pathophysiology of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 1991, 13, 97-107.
21. Cosgriff, T.M.; Lewis, R.M. Mechanisms of disease in hemorrhagic fever with renal syndrome. Kidney Int. Suppl. 1991, 35, S72-S79.
22. Khaiboullina, S.F.; St Jeor, S.C. Hantavirus immunology. Viral Immunol. 2002, 15, 609-625.
23. Terajima, M.; Vapalahti, O.; Van Epps, H.L.; Vaheri, A.; Ennis, F.A. Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect. 2004, 6, 238-245.
24. Borges, A.A.; Campos, G.M.; Moreli, M.L.; Souza, R.L.; Aquino, V.H.; Saggioro, F.P.; Figueiredo, L.T. Hantavirus cardiopulmonary syndrome: Immune response and pathogenesis. Microbes Infect. 2006, 8, 2324-2330.
25. Terajima, M.; Hayasaka, D.; Maeda, K.; Ennis, F.A. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol. Lett. 2007, 113, 117-120.
26. Koster, F.; Foucar, K.; Hjelle, B.; Scott, A.; Chong, Y.Y.; Larson, R.; McCabe, M. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am. J. Clin. Pathol. 2001, 116, 665-672.
27. Nolte, K.B.; Feddersen, R.M.; Foucar, K.; Zaki, S.R.; Koster, F.T.; Madar, D.; Merlin, T.L.; McFeeley, P.J.; Umland, E.T.; Zumwalt, R.E. Hantavirus pulmonary syndrome in the United States: A pathological description of a disease caused by a new agent. Hum. Pathol. 1995, 26, 110-120.
28. Huang, C.; Jin, B.; Wang, M.; Li, E.; Sun, C. Hemorrhagic fever with renal syndrome: Relationship between pathogenesis and cellular immunity. J. Infect. Dis. 1994, 169, 868-870.
29. Markotic, A.; Dasic, G.; Gagro, A.; Sabioncello, A.; Rabatic, S.; Kuzman, I.; Zgorelec, R.; Smoljan, I.; Beus, I.; Zupanc, T.A., et al. Role of peripheral blood mononuclear cell (PBMC) phenotype changes in the pathogenesis of haemorrhagic fever with renal syndrome (HFRS). Clin. Exp. Immunol. 1999, 115, 329-334.
30. Terajima, M.; Hendershot, J.D., Kariwa, H.; Koster, F.T.; Hjelle, B.; Goade, D.; DeFronzo, M.C.; Ennis, F.A. High levels of viremia in patients with the Hantavirus pulmonary syndrome. J. Infect. Dis. 1999, 180, 2030-2034.
31. Xiao, R.; Yang, S.; Koster, F.; Ye, C.; Stidley, C.; Hjelle, B. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J. Infect. Dis. 2006, 194, 1403-1409.
32. Mori, M.; Rothman, A.L.; Kurane, I.; Montoya, J.M.; Nolte, K.B.; Norman, J.E.; Waite, D.C.; Koster, F.T.; Ennis, F.A. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J. Infect. Dis. 1999, 179, 295-302.
33. Tracey, K.J.; Cerami, A. Tumor necrosis factor: A pleiotropic cytokine and therapuetic target. Annu. Rev. Med. 1994, 45, 491-503.
34. Thijs, L.G.; Hack, C.E.; Strack van Schijndel, R.J.; Nuijens, J.H.; Wolbink, G.J.; Eerenberg-Belmer, A.J.; Van der Vall, H.; Wagstaff, J. Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects. J. Immunol. 1990, 144, 2419-2424.
35. Wimer, B.M. Implications of the analogy between recombinant cytokine toxicities and manifestations of hantavirus infections. Canc. Biother. Rad. 1998, 13, 193-207.
36. Temonen, M.; Mustonen, J.; Helin, H.; Pasternack, A.; Vaheri, A.; Holthöfer, H. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: An immunohistochemical study. Clin. Immunol. Immunopathol. 1996, 78, 47-55.
37. Linderholm, M.; Ahlm, C.; Settergren, B.; Waage, A.; Tärnvik, A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 1996, 173, 38-43.
38. Taylor, S.L.; Frias-Staheli, N.; Garcia-Sastre, A.; Schmaljohn, C.S. Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J. Virol. 2009, 83, 1271-1279.
39. Taylor, S.L.; Krempel, R.L.; Schmaljohn, C.S. Inhibition of TNF-alpha-induced activation of NF-kappaB by hantavirus nucleocapsid proteins. Ann. N. Y. Acad. Sci. 2009, 1171, E86-E93.
40. Gavrilovskaya, I.N.; Gorbunova, E.E.; Mackow, N.A.; Mackow, E.R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 2008, 82, 5797-5806.
41. Dvorak, H.F.; Brown, L.F.; Detmar, M.; Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 1995, 146, 1029-1039.
42. Rothermel, A.L.; Wang, Y.; Schechner, J.; Mook-Kanamori, B.; Aird, W.C.; Pober, J.S.; Tellides, G.; Johnson, D.R. Endothelial cells present antigens in vivo. BMC Immunol. 2004, 5, 5.
43. Johnson, D.R. Endothelial cell-mediated antigen presentation. Transfus. Med. Hemother. 2006, 33, 58-70.
44. Zhao, M.Q.; Stoler, M.H.; Liu, A.N.; Wei, B.; Soguero, C.; Hahn, Y.S.; Enelow, R.I. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition. J. Clin. Invest. 2000, 106, R49-R58.
45. Xu, L.; Yoon, H.; Zhao, M.Q.; Liu, J.; Ramana, C.V.; Enelow, R.I. Cutting edge: Pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J. Immunol. 2004, 173, 721-725.
46. Rodig, N.; Ryan, T.; Allen, J.A.; Pang, H.; Grabie, N.; Chernova, T.; Greenfield, E.A.; Liang, S.C.; Sharpe, A.H.; Lichtman, A.H., et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 2003, 33, 3117-3126.
47. Mazanet, M.M.; Hughes, C.C. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 2002, 169, 3581-3588.
48. Eppihimer, M.J.; Gunn, J.; Freeman, G.J.; Greenfield, E.A.; Chernova, T.; Erickson, J.; Leonard, J.P. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 2002, 9, 133-145.
49. Björkstrom, N.K.; Lindgren, T.; Stoltz, M.; Fauriat, C.; Braun, M.; Evander, M.; Michaëlsson, J.; Malmberg, K.J.; Klingström, J.; Ahlm, C., et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 2011, 208, 13-21.
50. Janeway, C.A., Jr; Travers, P.; Hunt, S.; Walport, M. Antigen recognition by T lymphocytes. In Immunobiology: The Immune System in Health and Disease, 3rd ed.; Garland Publishing Inc.: New York, NY, USA, 1997; pp. 41-449.
51. Mustonen, J.; Partanen, J.; Kanerva, M.; Pietilä, K.; Vapalahti, O.; Pasternack, A.; Vaheri, A. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996, 49, 217-221.
52. Makela, S.; Mustonen, J.; Ala-Houhala, I.; Hurme, M.; Partanen, J.; Vapalahti, O.; Vaheri, A.; Pasternack, A. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J. Infect. Dis. 2002, 186, 843-846.
53. Plyusnin, A.; Horling, J.; Kanerva, M.; Mustonen, J.; Cheng, Y.; Partanen, J.; Vapalahti, O.; Kukkonen, S.K.; Niemimaa, J.; Henttonen, H., et al. Puumala hantavirus genome in patients with nephropathia epidemica: Correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J. Clin. Microbiol. 1997, 35, 1090-1096.
54. Mustonen, J.; Partanen, J.; Kanerva, M.; Pietilä, K.; Vapalahti, O.; Pasternack, A.; Vaheri, A. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand. J. Immunol. 1998, 47, 277-279.
55. Mustonen, J.; Huttunen, N.P.; Partanen, J.; Baer, M.; Paakkala, A.; Vapalahti, O.; Uhari, M. Human leukocyte antigens B8-DRB1*03 in pediatric patients with nephropathia epidemica caused by Puumala hantavirus. Pediatr. Infect. Dis. J. 2004, 23, 959-961.
56. Wang, M.L.; Lai, J.H.; Zhu, Y.; Zhang, H.B.; Li, C.; Wang, J.P.; Li, Y.M.; Yang, A.G.; Jin, B.Q. Genetic susceptibility to haemorrhagic fever with renal syndrome caused by Hantaan virus in Chinese Han population. Int. J. Immunogenet. 2009, 36, 227-229.
57. The Allele Frequency Net Database. Available online: http://www.allelefrequencies.net (accessed on 18 March 2011).
58. Gonzalez-Galarza, F.F.; Christmas, S.; Middleton, D.; Jones, A.R. Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011, 39, D913-D919.
59. Koster, F.; J. Vigil; D. Olson; M. Terajima; F. Ennis; Moehenkamp, C.; Williams, T. Class I, II and III HLA alleles associated with severe hantavirus cardiopulmonary syndrome in the southwest US (meeting abstract). Am. J. Trop. Med. 2001, 65, 152.
60. Kilpatrick, E.D.; Terajima, M.; Koster, F.T.; Catalina, M.D.; Cruz, J.; Ennis, F.A. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 2004, 172, 3297-3304.
61. Ferrer, C.P.; Vial, C.P.A.; Ferrés, G.M.; Godoy, M.P.; Culza, V.A.; Marco, C.C.; Castillo, H.C.; Umaña, C.M.E.; Rothhammer, E.F.; Llop, R.E. Genetic susceptibility to Andes Hantavirus: Association between severity of disease and HLA alíeles in Chilean patients. Revista chilena de infectología 2007, 24, 351-359.
62. Flatz, L.; Rieger, T.; Merkler, D.; Bergthaler, A.; Regen, T.; Schedensack, M.; Bestmann, L.; Verschoor, A.; Kreutzfeldt, M.; Brück, W., et al. T cell-dependence of Lassa fever pathogenesis. PLoS Pathog. 2010, 6, e1000836.
63. Peters, C.J. Viral Hemorrhagic Fevers. In Viral Pathogenesis; Nathanson, N., Ed.; Lippincott-Raven: Philadelphia, PA, USA, 1997; pp. 779-799.
64. Buchmeier, M.J.; de la Torre, J.-C.; Peters, C.J. Arenaviridae: The viruses and their replication. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp. 1793-1827.
65. Van Epps, H.L.; Schmaljohn, C.S.; Ennis, F.A. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: Identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J. Virol. 1999, 73, 5301-5308.
66. Terajima, M.; Van Epps, H.L.; Li, D.; Leporati, A.M.; Juhlin, S.E.; Mustonen, J.; Vaheri, A.; Ennis, F.A. Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. Virus Res. 2002, 84, 67-77.
67. Van Epps, H.L.; Terajima, M.; Mustonen, J.; Arstila, T.P.; Corey, E.A.; Vaheri, A.; Ennis, F.A. Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 2002, 196, 579-588.
68. Manigold, T.; Martinez, J.; Lazcano, X.; Ye, C.; Schwartz, S.; Cuiza, A.; Valdivieso, F.; Hjelle, B.; Vial, P. Case report: T-cell responses during clearance of Andes virus from blood cells 2 months after severe hantavirus cardiopulmonary syndrome. J. Med. Virol. 2008, 80, 1947-1951.
69. Manigold, T.; Mori, A.; Graumann, R.; Llop, E.; Simon, V.; Ferres, M.; Valdivieso, F.; Castillo, C.; Hjelle, B.; Vial, P. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog. 2010, 6, e1000779.
70. Ennis, F.A.; Cruz, J.; Spiropoulou, C.F.; Waite, D.; Peters, C.J.; Nichol, S.T.; Kariwa, H.; Koster, F.T. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 1997, 238, 380-390.
71. Lee, K.Y.; Chun, E.; Kim, N.Y.; Seong, B.L. Characterization of HLA-A2.1-restricted epitopes, conserved in both Hantaan and Sin Nombre viruses, in Hantaan virus-infected patients. J. Gen. Virol. 2002, 83, 1131-1136.
72. Wang, P.Z.; Huang, C.X.; Zhang, Y.; Li, Z.D.; Yo, H.T.; Zhang, Y.; Jia, Z.S.; Wang, J.P.; Lian, J.Q.; Sun, Y.T., et al. Analysis of the immune response to Hantaan virus nucleocapsid protein C-terminal-specific CD8(+) T cells in patients with hemorrhagic fever with renal syndrome. Viral Immunol. 2009, 22, 253-260.
73. Wilson, J.D.; Ogg, G.S.; Allen, R.L.; Davis, C.; Shaunak, S.; Downie, J.; Dyer, W.; Workman, C.; Sullivan, S.; McMichael, A.J., et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 2000, 14, 225-233.
74. Lechner, F.; Wong, D.K.; Dunbar, P.R.; Chapman, R.; Chung, R.T.; Dohrenwend, P.; Robbins, G.; Phillips, R.; Klenerman, P.; Walker, B.D. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 2000, 191, 1499-1512.
75. Lechner, F.; Gruener, N.H.; Urbani, S.; Uggeri, J.; Santantonio, T.; Kammer, A.R.; Cerny, A.; Phillips, R.; Ferrari, C.; Pape, G.R., et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 2000, 30, 2479-2487.
76. Thimme, R.; Oldach, D.; Chang, K.M.; Steiger, C.; Ray, S.C.; Chisari, F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001, 194, 1395-1406.
77. Sobao, Y.; Tomiyama, H.; Nakamura, S.; Sekihara, H.; Tanaka, K.; Takiguchi, M. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C. Hepatology 2001, 33, 287-294.
78. Maini, M.K.; Boni, C.; Ogg, G.S.; King, A.S.; Reignat, S.; Lee, C.K.; Larrubia, J.R.; Webster, G.J.; McMichael, A.J.; Ferrari, C., et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999, 117, 1386-1396.
79. Urbani, S.; Boni, C.; Missale, G.; Elia, G.; Cavallo, C.; Massari, M.; Raimondo, G.; Ferrari, C. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 2002, 76, 12423-12434.
80. Terajima, M.; Cruz, J.; Raines, G.; Kilpatrick, E.D.; Kennedy, J.S.; Rothman, A.L.; Ennis, F.A. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J. Exp. Med. 2003, 197, 927-932.
81. Mongkolsapaya, J.; Dejnirattisai, W.; Xu, X.N.; Vasanawathana, S.; Tangthawornchaikul, N.; Chairunsri, A.; Sawasdivorn, S.; Duangchinda, T.; Dong, T.; Rowland-Jones, S., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 2003, 9, 921-927.
82. Callan, M.F.; Tan, L.; Annels, N.; Ogg, G.S.; Wilson, J.D.; O'Callaghan, C.A.; Steven, N.; McMichael, A.J.; Rickinson, A.B. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 1998, 187, 1395-1402.
83. Annels, N.E.; Callan, M.F.; Tan, L.; Rickinson, A.B. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J. Immunol. 2000, 165, 4831-4841.
84. Catalina, M.D.; Sullivan, J.L.; Brody, R.M.; Luzuriaga, K. Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells. J. Immunol. 2002, 168, 4184-4191.
85. Hislop, A.D.; Annels, N.E.; Gudgeon, N.H.; Leese, A.M.; Rickinson, A.B. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 2002, 195, 893-905.
86. Wang, M.; Wang, J.; Zhu, Y.; Xu, Z.; Yang, K.; Yang, A.; Jin, B. Cellular immune response to Hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity. J. Infect. Dis. 2009, 199, 188-195.
87. Tuuminen, T.; Kekäläinen, E.; Mäkelä, S.; Ala-Houhala, I.; Ennis, F.A.; Hedman, K.; Mustonen, J.; Vaheri, A.; Arstila, T.P. Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. J. Immunol. 2007, 179, 1988-1995.
88. Hooper, J.W.; Li, D. Vaccines against hantaviruses. Curr. Top. Microbiol. Immunol. 2001, 256, 171-191.
89. Campen, M.J.; Milazzo, M.L.; Fulhorst, C.F.; Obot Akata, C.J.; Koster, F. Characterization of shock in a hamster model of hantavirus infection. Virology 2006, 356, 45-49.
90. Wahl-Jensen, V.; Chapman, J.; Asher, L.; Fisher, R.; Zimmerman, M.; Larsen, T.; Hooper, J.W. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J. Virol. 2007, 81, 7449-7462.
91. Milazzo, M.L.; Eyzaguirre, E.J.; Molina, C.P.; Fulhorst, C.F. Maporal viral infection in the Syrian golden hamster: A model of hantavirus pulmonary syndrome. J. Infect. Dis. 2002, 186, 1390-1395.
92. Eyzaguirre, E.J.; Milazzo, M.L.; Koster, F.T.; Fulhorst, C.F. Choclo virus infection in the Syrian golden hamster. Am. J. Trop. Med. Hyg. 2008, 78, 669-674.
93. Meyer, B.J.; Schmaljohn, C.S. Persistent hantavirus infections: Characteristics and mechanisms. Trends Microbiol. 2000, 8, 61-67.
94. Easterbrook, J.D.; Klein, S.L. Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 2008, 4, e1000172.
95. Mills, K.H. Regulatory T cells: Friend or foe in immunity to infection? Nat. Rev. Immunol. 2004, 4, 841-855.
96. Belkaid, Y.; Rouse, B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6, 353-360.
97. Easterbrook, J.D.; Zink, M.C.; Klein, S.L. Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 15502-15507.
98. Abel Borges, A.; Figueiredo, L.T. Mechanisms of shock in hantavirus pulmonary syndrome. Curr. Opin. Infect. Dis. 2008, 21, 293-297.
99. Zhu, L.Y.; Chi, L.J.; Wang, X.; Zhou, H. Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome. Clin. Exp. Immunol. 2009, 156, 88-96.
100. Sakaguchi, S.; Miyara, M.; Costantino, C.M.; Hafler, D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10, 490-500.
101. La Gruta, N.L.; Kedzierska, K.; Stambas, J.; Doherty, P.C. A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 2007, 85, 85-92.